478 related articles for article (PubMed ID: 30777210)
21. Evaluation of the European Society of Urogenital Radiology (ESUR) PI-RADS scoring system for assessment of extra-prostatic extension in prostatic carcinoma.
Schieda N; Quon JS; Lim C; El-Khodary M; Shabana W; Singh V; Morash C; Breau RH; McInnes MD; Flood TA
Eur J Radiol; 2015 Oct; 84(10):1843-8. PubMed ID: 26137904
[TBL] [Abstract][Full Text] [Related]
22. Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.
Abd-Alazeez M; Ramachandran N; Dikaios N; Ahmed HU; Emberton M; Kirkham A; Arya M; Taylor S; Halligan S; Punwani S
Prostate Cancer Prostatic Dis; 2015 Jun; 18(2):128-36. PubMed ID: 25644248
[TBL] [Abstract][Full Text] [Related]
23. Restriction spectrum imaging improves MRI-based prostate cancer detection.
McCammack KC; Schenker-Ahmed NM; White NS; Best SR; Marks RM; Heimbigner J; Kane CJ; Parsons JK; Kuperman JM; Bartsch H; Desikan RS; Rakow-Penner RA; Liss MA; Margolis DJ; Raman SS; Shabaik A; Dale AM; Karow DS
Abdom Radiol (NY); 2016 May; 41(5):946-53. PubMed ID: 26910114
[TBL] [Abstract][Full Text] [Related]
24. Quality assessment of prostate MRI by PI-QUAL score: Inter-reader agreement and impact on prostate cancer local staging at 3 Tesla.
Coelho FMA; Amaral LTW; Mitsutake LKN; Mussi TC; Baroni RH
Eur J Radiol; 2023 Aug; 165():110921. PubMed ID: 37336037
[TBL] [Abstract][Full Text] [Related]
25. Extra-prostatic extension grading system: correlation with MRI features and integration of capsular enhancement sign for "enhanced" detection of T3a lesions.
Martini F; Pigati M; Mattiauda M; Ponzano M; Piol N; Pigozzi S; Spina B; Cittadini G; Giasotto V; Zawaideh JP
Br J Radiol; 2024 May; 97(1157):971-979. PubMed ID: 38544291
[TBL] [Abstract][Full Text] [Related]
26. Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: a multi-reader study.
Rosenkrantz AB; Mussi TC; Hindman N; Lim RP; Kong MX; Babb JS; Melamed J; Taneja SS
Clin Radiol; 2012 Dec; 67(12):e83-90. PubMed ID: 22981729
[TBL] [Abstract][Full Text] [Related]
27. Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for the Prediction of Extraprostatic Disease-A Risk Model for Patient-tailored Risk Stratification When Planning Radical Prostatectomy.
Nyarangi-Dix J; Wiesenfarth M; Bonekamp D; Hitthaler B; Schütz V; Dieffenbacher S; Mueller-Wolf M; Roth W; Stenzinger A; Duensing S; Roethke M; Teber D; Schlemmer HP; Hohenfellner M; Radtke JP
Eur Urol Focus; 2020 Nov; 6(6):1205-1212. PubMed ID: 30477971
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Prostate Imaging Reporting and Data System versions 1 and 2 for the Detection of Peripheral Zone Gleason Score 3 + 4 = 7 Cancers.
Krishna S; McInnes M; Lim C; Lim R; Hakim SW; Flood TA; Schieda N
AJR Am J Roentgenol; 2017 Dec; 209(6):W365-W373. PubMed ID: 28981356
[TBL] [Abstract][Full Text] [Related]
29. Prostate cancer local staging using biparametric MRI: assessment and comparison with multiparametric MRI.
Christophe C; Montagne S; Bourrelier S; Roupret M; Barret E; Rozet F; Comperat E; Coté JF; Lucidarme O; Cussenot O; Granger B; Renard-Penna R
Eur J Radiol; 2020 Nov; 132():109350. PubMed ID: 33080549
[TBL] [Abstract][Full Text] [Related]
30. Effect of observation size and apparent diffusion coefficient (ADC) value in PI-RADS v2.1 assessment category 4 and 5 observations compared to adverse pathological outcomes.
Abreu-Gomez J; Walker D; Alotaibi T; McInnes MDF; Flood TA; Schieda N
Eur Radiol; 2020 Aug; 30(8):4251-4261. PubMed ID: 32211965
[TBL] [Abstract][Full Text] [Related]
31. [Diagnostic value of multiparametric MRI-based models in the assessment of extra-prostatic extension of prostate cancer].
Liu BC; Wang HY; Dong Z; Zhang Y; Bai X; Ding XH; Zhang XJ; Xu W; Zhao J; Hao YW; Ye HY
Zhonghua Yi Xue Za Zhi; 2023 May; 103(19):1439-1445. PubMed ID: 37198105
[No Abstract] [Full Text] [Related]
32. Prostate cancer: role of pretreatment multiparametric 3-T MRI in predicting biochemical recurrence after radical prostatectomy.
Park JJ; Kim CK; Park SY; Park BK; Lee HM; Cho SW
AJR Am J Roentgenol; 2014 May; 202(5):W459-65. PubMed ID: 24758681
[TBL] [Abstract][Full Text] [Related]
33. Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3 T.
Rosenkrantz AB; Kim S; Campbell N; Gaing B; Deng FM; Taneja SS
AJR Am J Roentgenol; 2015 Mar; 204(3):W266-72. PubMed ID: 25714311
[TBL] [Abstract][Full Text] [Related]
34. Detectability of low and intermediate or high risk prostate cancer with combined T2-weighted and diffusion-weighted MRI.
Doo KW; Sung DJ; Park BJ; Kim MJ; Cho SB; Oh YW; Ko YH; Yang KS
Eur Radiol; 2012 Aug; 22(8):1812-9. PubMed ID: 22466514
[TBL] [Abstract][Full Text] [Related]
35. A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).
Gaur S; Harmon S; Gupta RT; Margolis DJ; Lay N; Mehralivand S; Merino MJ; Wood BJ; Pinto PA; Shih JH; Choyke PL; Turkbey B
Acad Radiol; 2019 Jan; 26(1):5-14. PubMed ID: 29705281
[TBL] [Abstract][Full Text] [Related]
36. T-staging of prostate cancer: Identification of useful signs to standardize detection of posterolateral extraprostatic extension on prostate MRI.
Pesapane F; Standaert C; De Visschere P; Villeirs G
Clin Imaging; 2020 Jan; 59(1):1-7. PubMed ID: 31715511
[TBL] [Abstract][Full Text] [Related]
37. The role of T2-weighted images in assessing the grade of extraprostatic extension of the prostate carcinoma.
Onay A; Ertas G; Vural M; Colak E; Esen T; Bakir B
Abdom Radiol (NY); 2020 Oct; 45(10):3293-3300. PubMed ID: 32002569
[TBL] [Abstract][Full Text] [Related]
38. Can Extraprostatic Extension Be Predicted by Tumor-Capsule Contact Length in Prostate Cancer? Relationship With International Society of Urological Pathology Grade Groups.
Bakir B; Onay A; Vural M; Armutlu A; Yıldız SÖ; Esen T
AJR Am J Roentgenol; 2020 Mar; 214(3):588-596. PubMed ID: 31670596
[No Abstract] [Full Text] [Related]
39. A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.
Mehralivand S; Shih JH; Harmon S; Smith C; Bloom J; Czarniecki M; Gold S; Hale G; Rayn K; Merino MJ; Wood BJ; Pinto PA; Choyke PL; Turkbey B
Radiology; 2019 Mar; 290(3):709-719. PubMed ID: 30667329
[TBL] [Abstract][Full Text] [Related]
40. Multiparametric 3T MRI for the prediction of pathological downgrading after radical prostatectomy in patients with biopsy-proven Gleason score 3 + 4 prostate cancer.
Gondo T; Hricak H; Sala E; Zheng J; Moskowitz CS; Bernstein M; Eastham JA; Vargas HA
Eur Radiol; 2014 Dec; 24(12):3161-70. PubMed ID: 25100337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
